UCB SA has appointed Anna Richo as new executive vice president, or EVP, and general counsel, effective November 1, 2012. Anna will be a member of UCB's executive committee and she will report to Roch Doliveux, UCB's CEO and chairman of the executive committee. Anna succeeds Bob Trainor, the company's EVP and general counsel since 2004, who will retire by the end of 2012.

Anna Richo joins UCB from Amgen Inc. where since 2008 she was senior vice president and chief compliance officer reporting to the president and CEO and to Amgen's corporate responsibility & compliance committee of the board of directors.